医学
加巴喷丁
巴氯芬
麻醉
腰椎管狭窄症
随机对照试验
Oswestry残疾指数
不利影响
腰椎
腰痛
物理疗法
外科
内科学
受体
替代医学
病理
兴奋剂
作者
Hee Jung Kim,Kyung Bong Yoon,Mi‐Sun Kang,Hee Won Lee,Shin Hyung Kim
出处
期刊:American Journal of Physical Medicine & Rehabilitation
[Ovid Technologies (Wolters Kluwer)]
日期:2023-11-22
卷期号:103 (5): 384-389
标识
DOI:10.1097/phm.0000000000002364
摘要
Objective This study aimed to compare the efficacy and safety of baclofen and gabapentin in reducing leg pain from nocturnal calf cramps in lumbar spinal stenosis patients. Design In a randomized clinical trial, the patients with lumbar spinal stenosis who commonly experienced nocturnal calf cramps were included. Patients were randomly assigned to either the baclofen or gabapentin group. Overall leg pain intensity, nocturnal calf cramp frequency and severity, sleep disturbances and functional disability were assessed at baseline and after 4 and 12 wks. Results Thirty-six patients completed the 3-mo study. Both gabapentin and baclofen groups showed a significant reduction in overall leg pain, calf cramp frequency and intensity, and insomnia severity index scores from baseline to the endpoint. However, there were no significant differences between the two groups in terms of symptom reduction at different time points. The baclofen group also demonstrated a significant decrease in Oswestry Disability Index scores ( P < 0.001), while the gabapentin group did not ( P = 0.344). No adverse effects were reported in either group. Conclusions Baclofen seems to be as effective and as safe as gabapentin in treating nocturnal calf cramps in lumbar spinal stenosis patients and even shows superiority in enhancing functional outcomes.
科研通智能强力驱动
Strongly Powered by AbleSci AI